Bookmark
Forward
On aspirin treatment but not baseline thromboxane B2 levels predict adverse outcomes in patients with acute coronary syndromes.
E Matsuura, K Guyer, H Yamamoto, L R Lopez, K Inoue
Journal of thrombosis and haemostasis : JTH 2012 Sep
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
E Matsuura, K Guyer, H Yamamoto, L R Lopez, K Inoue.
On aspirin treatment but not baseline thromboxane B2 levels predict adverse outcomes in patients with acute coronary syndromes.
Journal of thrombosis and haemostasis : JTH.
2012 Sep;10(9):1949-51
Mesh Tags
Acute Coronary Syndrome
Aspirin
Humans
Thromboxane B2
Substances
Thromboxane B2
Aspirin
PMID: 22784188
View Full Text